Howard Lee
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Otorhinolaryngology top 5%
Papers in
- Oncology 15
- Immunology 12
- Biosimilars and Bioanalytical Methods 6
- Co-authors
- Carl C. Peck (5 shared papers)Kyung‐Sang Yu (25 shared papers)In‐Jin Jang (18 shared papers)Kyoung Soo Lim (14 shared papers)Joo‐Youn Cho (13 shared papers)Julius Chapiro (7 shared papers)Rafael Durán (7 shared papers)MingDe Lin (7 shared papers)
- Journals
- Drug Design Development and Therapy (10 papers)Clinical and Translational Science (10 papers)International Journal of Agricultural Sustainability (5 papers)The Journal of Clinical Pharmacology (4 papers)Clinical Therapeutics (4 papers)
- Partner nations
- United StatesSouth KoreaPuerto Rico
In The Last Decade
Howard Lee
160 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 174
- Hepatology 214
- Otorhinolaryngology 99
- Pharmacology 132
- Family Practice 24
- Hematology 149
Countries citing papers authored by Howard Lee
This map shows the geographic impact of Howard Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Lee more than expected).
Fields of papers citing papers by Howard Lee
This network shows the impact of papers produced by Howard Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Lee. The network helps show where Howard Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Howard Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 169 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 108 | |
| 2 | 1997 | 106 | |
| 3 | 2002 | 98 | |
| 4 | 2006 | 97 | |
| 5 | 2015 | 94 | |
| 6 | 2015 | 93 | |
| 7 | 2003 | 86 | |
| 8 | 2009 | 83 | |
| 9 | 2013 | 70 | |
| 10 | 1977 | 67 | |
| 11 | 1989 | 65 | |
| 12 | 2005 | 65 | |
| 13 | 2016 | 62 | |
| 14 | 2005 | 62 | |
| 15 | 1984 | 57 | |
| 16 | 2020 | 51 | |
| 17 | 2022 | 48 | |
| 18 | 2013 | 44 | |
| 19 | 2011 | 43 | |
| 20 | 2010 | 43 |
About Howard Lee
Howard Lee is a scholar working on Oncology, Immunology, Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Pediatrics, Perinatology and Child Health, having authored 169 papers that have together received 3.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), Pharmacogenetics and Drug Metabolism (7 papers), Pharmaceutical studies and practices (7 papers), Statistical Methods in Clinical Trials (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Biosimilars and Bioanalytical Methods (6 papers), Diabetes Treatment and Management (6 papers) and Blood Pressure and Hypertension Studies (5 papers). The work is most often cited by research in Hepatology (214 citations), Otorhinolaryngology (99 citations), Pharmacology (132 citations), Family Practice (24 citations) and Hematology (149 citations). Howard Lee has collaborated with scholars based in United States, South Korea and Puerto Rico. Frequent co-authors include Carl C. Peck, Kyung‐Sang Yu, In‐Jin Jang, Kyoung Soo Lim, Joo‐Youn Cho, Julius Chapiro, Rafael Durán, MingDe Lin, Honghui Zhou and Nam P. Nguyen. Their work appears in journals such as Drug Design Development and Therapy, Clinical and Translational Science, International Journal of Agricultural Sustainability, The Journal of Clinical Pharmacology and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.